SEC Form 4 · accession 0000921895-15-001883
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur M Langer
Director
Period of report
Aug 4, 2015
Accepted (ET)
Aug 6, 2015 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 50,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Aug 4, 2015 | A | 14,245 | A | — | — | Common Stock | 14,245 | 14,245 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F2These Restricted Stock Units are scheduled to vest on August 4, 2016.